BioLargo (BioLargo) Days Sales Outstanding : 42.44 (As of Dec. 2023)

View and export this data going back to 1991. Start your Free Trial

What is BioLargo Days Sales Outstanding?

BioLargo's average Accounts Receivable for the three months ended in Dec. 2023 was $2.03 Mil. BioLargo's Revenue for the three months ended in Dec. 2023 was $4.37 Mil. Hence, BioLargo's Days Sales Outstanding for the three months ended in Dec. 2023 was 42.44.

The historical rank and industry rank for BioLargo's Days Sales Outstanding or its related term are showing as below:

BLGO' s Days Sales Outstanding Range Over the Past 10 Years
Min: 16.29 Med: 58.66 Max: 71.89
Current: 45.04

During the past 13 years, BioLargo's highest Days Sales Outstanding was 71.89. The lowest was 16.29. And the median was 58.66.

BLGO's Days Sales Outstanding is ranked better than
72.21% of 1526 companies
in the Chemicals industry
Industry Median: 63.525 vs BLGO: 45.04

BioLargo's Days Sales Outstanding increased from Dec. 2022 (42.36) to Dec. 2023 (42.44).

BioLargo Days Sales Outstanding Historical Data

The historical data trend for BioLargo's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioLargo Days Sales Outstanding Chart

BioLargo Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

60.02

62.96

71.89

48.91

54.85

BioLargo Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial															42.36	29.80	76.26	42.52	42.44

Competitive Comparison of BioLargo's Days Sales Outstanding

For the Chemicals subindustry, BioLargo's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BioLargo's Days Sales Outstanding Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, BioLargo's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where BioLargo's Days Sales Outstanding falls into.

BioLargo Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

BioLargo's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (1.064	+	2.612)	/	2 )	/	12.23	*	365
=	1.838					/	12.23	*	365
=	54.85

BioLargo's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Sep. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (1.453	+	2.612)	/	2 )	/	4.37	*	365 / 4
=	2.0325					/	4.37	*	365 / 4
=	42.44

BioLargo (OTCPK:BLGO) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

BioLargo Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of BioLargo's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

BioLargo (BioLargo) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » BioLargo Inc (OTCPK:BLGO) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

14921 Chestnut Street, Westminster, CA, USA, 92683

Website

https://www.biolargo.com

BioLargo Inc invents, develops, and commercializes platform technologies to solve challenging environmental problems like PFAS contamination, advanced water, and wastewater treatment, industrial odor, and VOC control, air quality control, and infection control. The company holds a wide array of issued patents, maintains a robust pipeline of products, and provides full-service environmental engineering. BioLargo invents or acquires novel technologies and develops them to maturity through its operating subsidiaries. It monetizes through direct sales, recurring service contracts, licensing agreements, strategic joint venture formation, and/or the sale of the IP. The firm's technologies are commercially available and are advancing as disrupters in their respective markets.

Executives

Linda Park	director	14921 CHESTNUT STREET, WESTMINSTER CA 92683
Christina Elaine Bray	director	PO BOX 234, FREDERICK CO 80530
Jack B. Strommen	director	7108 31ST AVENUE N., MINNEAPOLIS MN 55427
Roberts Kent Charles Ii	director	1146 OXFORD ROAD, SAN MARINO CA 91108
John S. Runyan	director	30001 HILLSIDE TERRACE, SAN JUAN CAPISTRANO CA 92675
Dennis E Marshall	director	3500 W. GARRY AVENUE, SANTA ANA CA 92705
Dennis P Calvert	director, 10 percent owner, officer: Chief Executive Officer	3500 GARRY AVE, SANTA ANA CA 92704
New Millennium Capital Partners, Llc	10 percent owner	16333 PHOEBE AVENUE, LA MIRADA CA 90638
Charles K Dargan	officer: Chief Financial Officer	8055 W. MANCHESTER AVE., SUITE 405, PLAYA DEL REY CA 90293
Joseph L Provenzano	director, officer: Corporate Secretary	3500 W. GARRY AVENUE, SANTA ANA CA 92704
Iowc Technologies, Inc.	10 percent owner	2603 MAIN STREET, SUITE 1155, IRVINE CA 92614
Kenneth Reay Code	10 percent owner	16150 HERON AVENUE, LA MIRADA CA 90638
Gary Adrian Cox	director	3500 W. GARRY AVENUE, SANTA ANA CA 92705
Steven V Harrison	director
Eduardo Ruiz	director, 10 percent owner